Interaction Between Fluids and Vasoactive Agents on Mortality in Septic Shock: A Multicenter, Observational Study*

Objective:Fluids and vasoactive agents are both used to treat septic shock, but little is known about how they interact or the optimal way to administer them. We sought to determine how hospital mortality was influenced by combined use of these two treatments. Design:Retrospective evaluation using multivariable logistic regression to evaluate the association between hospital mortality and categorical variables representing initiation of vasoactive agents and volumes of IV fluids given 0–1, 1–6, and 6–24 hours after onset, including interactions and adjusting for potential confounders. Setting:ICUs of 24 hospitals in 3 countries. Patients:Two thousand eight hundred forty-nine patients who survived more than 24 hours after after onset of septic shock, admitted between 1989 and 2007. Interventions:None. Measurements and Main Results:Fluids and vasoactive agents had strong, interacting associations with mortality (p < 0.0001). Mortality was lowest when vasoactive agents were begun 1–6 hours after onset, with more than 1 L of fluids in the initial hour after shock onset, more than 2.4 L from hours 1–6, and 1.6–3.5 L from 6 to 24 hours. The lowest mortality rates were associated with starting vasoactive agents 1–6 hours after onset. Conclusions:The focus during the first hour of resuscitation for septic shock should be aggressive fluid administration, only thereafter starting vasoactive agents, while continuing aggressive fluid administration. Starting vasoactive agents in the initial hour may be detrimental, and not all of that association is due to less fluids being given with such early initiation of vasoactive agents.

[1]  J E Parrillo,et al.  Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. , 2001, Journal of cardiothoracic and vascular anesthesia.

[2]  Ruth Ann Marrie,et al.  Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables. , 2009, Journal of clinical epidemiology.

[3]  L. Papazian,et al.  Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? , 1992, Chest.

[4]  M. Jacob,et al.  A Rational Approach to Perioperative Fluid Management , 2008, Anesthesiology.

[5]  J. Parrillo,et al.  Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis , 2009, Intensive Care Medicine.

[6]  S. Goldstein,et al.  Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care. , 2016, The New England journal of medicine.

[7]  S. Bagshaw,et al.  Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy , 2009, Intensive Care Medicine.

[8]  J. Bakker,et al.  Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. , 2010, American journal of respiratory and critical care medicine.

[9]  Michal Abrahamowicz,et al.  Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. , 2005, American journal of epidemiology.

[10]  D. Cook,et al.  Resuscitating patients with early severe sepsis: A Canadian multicentre observational study , 2007, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[11]  Jeffrey A. Kline,et al.  The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: A meta-analysis* , 2008, Critical care medicine.

[12]  P. Lacolley,et al.  Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock* , 2007, Critical care medicine.

[13]  J. Vincent.  Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. , 2004, American journal of respiratory and critical care medicine.

[14]  K. Maitland,et al.  Mortality after fluid bolus in African children with severe infection. , 2011, The New England journal of medicine.

[15]  R. Bellomo,et al.  Hydroxyethyl starch or saline for fluid resuscitation in intensive care. , 2012, The New England journal of medicine.

[16]  Sangeeta Mehta,et al.  Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.

[17]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[18]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[19]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[20]  J. Marshall.  Sepsis research: where have we gone wrong? , 2006, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[21]  S. Steele,et al.  Serum lactate and base deficit as predictors of mortality and morbidity. , 2003, American journal of surgery.

[22]  E. Ruokonen,et al.  Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial , 2009, Critical care.

[23]  S. Hollenberg.  Vasopressor support in septic shock. , 2007, Chest.

[24]  M. Mathru.  Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock , 2010 .

[25]  Djillali Annane,et al.  Current epidemiology of septic shock: the CUB-Réa Network. , 2003, American journal of respiratory and critical care medicine.

[26]  Didier Payen,et al.  Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study* , 2006, Critical care medicine.

[27]  J. Vincent,et al.  Vasopressor and inotropic support in septic shock: An evidence-based review , 2004, Critical care medicine.

[28]  Anand Kumar,et al.  Early intravenous unfractionated heparin and mortality in septic shock* , 2008, Critical care medicine.

[29]  Taka-aki Nakada,et al.  Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality* , 2011, Critical care medicine.

[30]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[31]  S. Zanotti-Cavazzoni.  Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy , 2010 .

[32]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.